Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.35 |
| ▸ | NQO2 | P16083 | 1/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.33 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.33 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26293059 | 0.83 | CA1 (0.30) | CA1CA2CA9 | |
| SCHEMBL14800228 | 0.80 | CYP2A6 (0.47) | CYP2A6CA1CA2CA7CA9 | |
| SCHEMBL9095175 | 0.80 | CYP2A6 (0.55) | CYP2A6CA1CA2CA7CA9 | |
| SCHEMBL30548751 | 0.80 | CYP2A6 (0.47) | CYP2A6CA1CA2CA7CA9 | |
| SCHEMBL29374851 | 0.80 | CYP2A6 (0.55) | CYP2A6CA1CA2CA7CA9 | |
| SCHEMBL22500002 | 0.80 | MAOB (0.43) | CYP2A6ALDH1A1HSD17B10HIF1ATDP1 | |
| SCHEMBL28769813 | 0.77 | SLC9A1 (0.37) | CA9ALDH1A1HSD17B10HIF1ACYP1B1 | |
| SCHEMBL3259247 | 0.75 | CYP2A6 (0.50) | CYP2A6CA1CA2CA7CA9 | |
| SCHEMBL5008807 | 0.75 | CYP2A6 (0.50) | CYP2A6CA1CA2CA7CA9 | |
| SCHEMBL3465676 | 0.75 | CYP2A6 (0.50) | CYP2A6CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114956948-A | Industrial production method of 2-bromo-3-halogenated naphthalene | 西安瑞联新材料股份有限公司 | 2022-08-30 | — | — | CN | claimed |
| EP-4745212-A1 | NEW COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | TOP RUN MATERIAL SOLUTION Co., Ltd. (KR) | 2026-05-20 | — | — | EP | disclosed |
| CN-122036721-A | Novel compound and organic light emitting device comprising the same | 株式会社进雄产业 | 2026-05-15 | — | — | CN | disclosed |
| US-20260136757-A1 | NEW COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | TOP RUN MAT SOLUTION CO LTD (KR) | 2026-05-14 | — | — | US | disclosed |
| EP-4400559-B1 | LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND | SAMSUNG DISPLAY CO LTD (KR) | 2025-10-22 | — | — | EP | disclosed |
| US-20250261501-A1 | LIGHT EMITTING ELEMENT AND METHOD FOR PRODUCING THE SAME, LIGHT EMITTING COMPOUND AND METHOD FOR PRODUCING THE SAME, COMPOSITION AND METHOD FOR PRODUCING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-08-14 | — | — | US | disclosed |
| CN-120201863-A | Organic electroluminescent device | SFC株式会社 | 2025-06-24 | — | — | CN | disclosed |
| CN-118994173-B | Compound, organic electroluminescent device comprising same and display device | 阜阳欣奕华新材料科技股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-12240864-B2 | Phosphine oxide group-contained transition metal complex, and polymer, mixture, composition, and organic electronic device thereof | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2025-03-04 | — | — | US | disclosed |
| EP-4498778-A1 | LIGHT-EMITTING ELEMENT AND PRODUCTION METHOD THEREFOR, LIGHT-EMITTING COMPOUND AND PRODUCTION METHOD THEREFOR, COMPOSITION AND PRODUCTION METHOD THEREFOR, INFORMATION PROCESSING METHOD, INFORMATION PROCESSING DEVICE, PROGRAM, METHOD FOR PROVIDING LIGHT-EMITTING COMPOUND, AND DATA GENERATION METHOD | Sumitomo Chemical Company, Limited (JP) | 2025-01-29 | — | — | EP | disclosed |
| US-20090023957-A1 | TERPHENYLENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING BOTH | TOSOH CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20090023957-A1 | TERPHENYLENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING BOTH | TOSOH CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20090023957-A1 | TERPHENYLENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING BOTH | TOSOH CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20080161592-A1 | PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | CEPTYR, INC. (US) | 2008-07-03 | — | — | US | disclosed |
| CN-101094677-A | Protein tyrosine phosphatase inhibitors and methods of use thereof | CEPTYR INC (US) | 2007-12-26 | — | — | CN | disclosed |
| EP-1867623-A1 | TERPHENYLENE DERIVATIVES, TETRAHALOTERPHENYL DERIVATIVES AND PROCESSES FOR THE PRODUCTION OF BOTH | Tosoh Corporation (JP) | 2007-12-19 | — | — | EP | disclosed |
| EP-1812012-A2 | PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | Ceptyr, Inc. (US) | 2007-08-01 | — | — | EP | disclosed |
| JP-2006328005-A | METHOD FOR PRODUCING DIHALOGENATED BIARYL DERIVATIVE | TOSOH CORP | 2006-12-07 | — | — | JP | disclosed |
| US-20060142250-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | FALCON TECHNOLOGY PARTNERS L.P. | 2006-06-29 | — | — | US | disclosed |
| WO-2006055525-A2 | PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | CEPTYR, INC. (US) | 2006-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12240864-B2 | Phosphine oxide group-contained transition metal complex, and polymer, mixture, composition, and organic electronic device thereof | PHOSPHO1, CPNE4, TCP1 | CYP2A6 4369/4885CA1 1240/4885CA2 1569/4885 |
| US-20080161592-A1 | PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | PPM1B, PTPN1, PTPN5 | CYP2A6 1923/4885CA1 4190/4885CA2 4174/4885 |
| US-20060142250-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | PPM1B, PTPN1, PTPN5 | CYP2A6 1923/4885CA1 4190/4885CA2 4174/4885 |
| US-20260136757-A1 | NEW COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | CCNL2, TBL3, HBS1L | CYP2A6 1554/4885CA1 2267/4885CA2 1538/4885 |
| US-20090023957-A1 | TERPHENYLENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING BOTH | TERT, TLN1, TTI1 | CYP2A6 1779/4885CA1 1015/4885CA2 1792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.